NCT00321568 Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis Status COMPLETED Phase N/A
NCT00313976 Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) Status WITHDRAWN Phase PHASE3
NCT00300716 Trial of Memantine for Cognitive Impairment in Multiple Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT00298662 Combination Therapy of Betaseron-Prograf in Multiple Sclerosis Status UNKNOWN Phase PHASE2
NCT00291148 Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain Status COMPLETED Phase PHASE3
NCT00289159 Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up Status UNKNOWN Phase N/A
NCT00288990 A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis Status COMPLETED Phase N/A
NCT00280592 Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients Status COMPLETED Phase PHASE3
NCT00278655 Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Status TERMINATED Phase PHASE1/PHASE2
NCT00273364 Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study Status COMPLETED Phase PHASE2
NCT00270816 Interferon ß-1b Treatment by Cyclical Administration Status COMPLETED Phase PHASE2/PHASE3
NCT00262314 Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients Status COMPLETED Phase N/A
NCT00248378 Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2